You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歸創通橋-B(02190.HK)獲開發商業化IVL系統獨家許可
阿思達克 11-15 09:48
歸創通橋-B(02190.HK)公布,與杭州天路醫療器械訂立合作協議,天路將公司就開發用於治療外周血管疾病的血管內碎石(IVL)系統授出若干專有技術的獨家許可。根據合作協議,公司有權在全世界開發、製造及商業化IVL系統,而天路則有權獲得若干經濟利益,如預付款項、里程碑付款及銷售權利金。 公司表示,天路所開發的技術有待全球專利保護,將使歸創通橋開發出用於治療中度及重度鈣化動脈的IVL系統,基於演示系統的數據及表現已證實其安全有效。該系統包括IVL主機、IVL連接線、IVLPTA球囊擴張導管及IVL加強型藥塗球囊擴張導管,為公司對下肢動脈疾病全線解決方案管理的最新項目。公司將繼續開發更多產品。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account